top of page
5 days ago
2/6 BioPhenoMA launches "TN-cyclon™ ELISA Development Kit"
BioPhenoMA launches the new ultra-sensitive protein detection reagent kit (Product Name: “TN-cyclon™ ELISA Development Kit”) for research...
5 days ago
2/6 Published in The Nikkan Kogyo Shimbun
The Article about our new reagent kit for research was published in The Nikkan Kogyo Shimbun. Read the article (Japanese):...
Dec 6, 2024
12/3 Selected for Plug and Play Accelerator Program
BioPhenoMA has been selected as one of the companies in the Health category of the Winter/Spring 2025 Q1 Batch accelerator program by...
Dec 2, 2024
12/2 Paper published in Frontiers in Immunology
Frontiers in Immunology Vol. 15 (December issue) published our article “Ultrasensitive protein-level detection for respiratory infectious...
Nov 28, 2024
11/28 BioPhenoMA launches the ultra-sensitive PD-L1 detection kit for research use and starts sales on the website.
BioPhenoMA launches the ultra-sensitive PD-L1 detection reagent kit (Product Name: “PD-L1 TN-cyclon™ ELISA Kit”) for research use and...
Nov 22, 2024
11/21 Poster Presentation at “CHEMINAS 50” by our engineer, Tatsuya Shima, on November 25.
Our engineer, Tatsuya Shima, will give a poster presentation at the 50th annual conference of the Society for Chemistry and Micro-Nano...
Nov 13, 2024
11/7 BioPhenoMA raises 190M JPY in Pre-Series A fundraising round
BioPhenoMA, Inc. (Shinjuku-Ku, Tokyo, Representative Director Daisuke Niwa, CEO Naoto Fujii) raised 190 million JPY from WASEDA...
Sep 30, 2024
9/26 We have been commissioned by Chase Therapeutics to conduct research on the diagnosis of Parkinson's disease.
We have entered into a research agreement with Chase Therapeutics (Washington D.C., USA), a startup focused on drug discovery, to develop...
Sep 30, 2024
9/26 Research collaboration has begun on blood biomarker test reagents for Alzheimer's disease
A research collaboration with a Japanese manufacturer has been initiated for a blood biomarker test reagent for Alzheimer's disease....

Sep 25, 2024
9/25 We will participate in BioJapan2024
We will be participating in BioJapan2024 and will have a booth and a presentation. Event Details: - BioJapan2024 will take place from...
Sep 9, 2024
9/9 Our CEO will make a speech at "earthkey pitch vol.132 & AWARD" on September 11.
Naoto Fujii, our CEO, is scheduled to take the stage from 4:22 p.m.. This event is a startup pitch event hosted by eathkey Inc.. You can...
Aug 7, 2024
8/7 Our company has been selected for the "NEXs Tokyo" overseas expansion support program (5th gen)
Our company has been selected for the "NEXs Tokyo" overseas expansion support program (5th gen), an innovation creation project supported...

Jul 22, 2024
7/26 Pitch at CGT-Vax Discovery Symposium, Bio Asia Taiwan
On July 26, Bio Asia Taiwan held GT-Vax Discovery Symposium, and our CEO will pitch on the stage.Come see us at Taipei Nangang Exhibition...
Jul 22, 2024
7/19 TOKYO REGIONAL 2024
We will be presenting a booth at TOKYO REGIONAL2024 at Grand Hyatt Tokyo. Discover our technology in Startup Exhibition Room at the 2nd...
Jun 19, 2024
6/24 We will have a booth at the symposium "Frontier of Drug Discovery 2024"
We will have a booth at "Frontier of Drug Discovery 2024" hosted by LINK-J on Monday, June 24. For more information, please visit...
Jun 19, 2024
6/20 VENTURE PITCH ONLINE Vol. 73, co-hosted by Nomura Securities
The presentation will be made at "VENTURE PITCH Vol73" co-hosted by Nomura Securities on Thursday, June 20. https://vp73.peatix.com/?utm_...
Mar 21, 2024
3/21 Featured in Nikkei Biotech
Introduced in the Nikkei Biotech serial "Biotech Venture Exploration". https://bio.nikkeibp.co.jp/atcl/column/16/021500017/031500325/
Feb 20, 2024
3/17 We will participate in the Lifescience Start up Career Fair.
On Sunday, March 17, we will participate in a career fair for researchers, salespeople, and managers of life science startups....
Feb 6, 2024
1/31 We joined "i2.JP"
We joined i2.JP an open innovation network led by AstraZeneca. For more information, please visit the website https://www.i2jp.net/en/ind...

Jan 29, 2024
1/26 We are thrilled to announce our upcoming partnership with Tokyo Medical University for a joint research project.
BioPhenoMA Inc. and Tokyo Medical University have established a collaborative research initiative to create novel biomarkers for...
bottom of page